The electricity it makes is expensive, its technology has been superseded, and it's incinerating thousands of birds ...

Haemonetics (NYSE: HAE) announced today that it acquired percutaneous vessel closure device maker Vivasure Medical.

EQUASHIELD’s groundbreaking Mundus Compounding System sets a new standard in safety, workflow efficiency, and USP-ready compliance. Modular hazardous drug compounder sets a new standard in safety, ...

The MarketWatch News Department was not involved in the creation of this content. PORT WASHINGTON, N.Y., Dec. 3, 2025 /PRNewswire/ -- EQUASHIELD(R) , a global leader in Closed System Transfer Devices ...

PORT WASHINGTON, N.Y., Dec. 3, 2025 /PRNewswire/ -- EQUASHIELD ®, a global leader in Closed System Transfer Devices (CSTD) and pharmacy automation, will highlight its fully integrated hazardous drug ...